checkAd
    Startseite > Aktien > DiaMedica Therapeutics > Nachrichten
    DiaMedica Therapeutics Aktie
    3,0200
     
    USD
    -5,33 %
    -0,1700 USD
    Letzter Kurs 02:00:00 Nasdaq
    3,0200
     
    USD
    100 STK
    Geldkurs 16:18:02
    3,0500
     
    USD
    100 STK
    Briefkurs 16:18:02
    ISIN: CA25253X2077 · WKN: A2N9HB · SYM: DMAC · Kanada

    Neueste Nachrichten

    DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results
    08.05.24 · Business Wire (engl.) · DiaMedica Therapeutics
    DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024
    02.05.24 · Business Wire (engl.) · DiaMedica Therapeutics
    DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
    17.04.24 · Business Wire (engl.) · DiaMedica Therapeutics
    DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
    19.03.24 · Business Wire (engl.) · DiaMedica Therapeutics
    DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference
    29.01.24 · Business Wire (engl.) · DiaMedica Therapeutics
    DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer
    22.01.24 · Business Wire (engl.) · DiaMedica Therapeutics
    DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
    13.11.23 · Business Wire (engl.) · DiaMedica Therapeutics
    DiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023
    09.11.23 · Business Wire (engl.) · DiaMedica Therapeutics
    DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023
    06.11.23 · Business Wire (engl.) · DiaMedica Therapeutics
    DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer
    12.09.23 · Business Wire (engl.) · DiaMedica Therapeutics
    DiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth Conference
    06.09.23 · Business Wire (engl.) · DiaMedica Therapeutics
    DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results
    14.08.23 · Business Wire (engl.) · DiaMedica Therapeutics